Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $57.31 in the prior trading day, Apogee Therapeutics Inc. (NASDAQ: APGE) closed at $56.23, down -1.88%. In other words, the price has decreased by -$1.88 from its previous closing price. On the day, 0.51 million shares were traded. APGE stock price reached its highest trading level at $57.15 during the session, while it also had its lowest trading level at $55.44.
Ratios:
Our goal is to gain a better understanding of APGE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.70 and its Current Ratio is at 27.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 10, 2024, initiated with a Buy rating and assigned the stock a target price of $80.
On December 20, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $43.
On August 08, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $40.Wedbush initiated its Outperform rating on August 08, 2023, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 02 ’24 when CARL DAMBKOWSKI bought 16,010 shares for $57.31 per share.
HENDERSON MICHAEL THOMAS bought 40,000 shares of APGE for $2,249,176 on Oct 02 ’24. On Sep 04 ’24, another insider, Dambkowski Carl, who serves as the Chief Medical Officer of the company, sold 6,665 shares for $47.56 each. As a result, the insider received 316,969 and left with 280,793 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APGE now has a Market Capitalization of 3187172608 and an Enterprise Value of 2616506112.
Stock Price History:
Over the past 52 weeks, APGE has reached a high of $72.29, while it has fallen to a 52-week low of $14.19. The 50-Day Moving Average of the stock is 14.21%, while the 200-Day Moving Average is calculated to be 23.12%.
Shares Statistics:
The stock has traded on average 419.69K shares per day over the past 3-months and 548700 shares per day over the last 10 days, according to various share statistics. A total of 37.17M shares are outstanding, with a floating share count of 36.29M. Insiders hold about 37.94% of the company’s shares, while institutions hold 77.00% stake in the company. Shares short for APGE as of 1726185600 were 8185156 with a Short Ratio of 19.50, compared to 1723680000 on 8185424. Therefore, it implies a Short% of Shares Outstanding of 8185156 and a Short% of Float of 21.290001.
